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Abstract This is an observational case series of 15
patients with full-thickness traumatic wound defects trea-
ted with a dermal substitute. There were 8 male and 7
female patients with a mean age of 36.6 years. Eight
patients had trauma to the lower limbs and 7 were of the
upper limbs, with the average lesion size 104.4 cm2 (range
6–490 cm2). The time to complete healing had a mean
average time of 26.8 days (range 16–60 days). All patients
went on to successful repair with 6 patients requiring a
second application of the substitute and 5 patients needing
split thickness skin grafts. Infection was recorded in one
patient.
Keywords Upper limb  Lower limb  Hyaluronic
acid  Full-thickness wound
Introduction
In the last few decades, there has been a search for solu-
tions in tissue repair without need for autografts. This has
produced a development of biological substitutes that could
repair or improve the function of tissue. The use of these
products enlarges the spectrum of therapeutic resources
available for the treatment of skin lesions, thereby chang-
ing the approach to many diseases [1]. The advent of
so-called advanced wound care dressings has revolution-
ized the treatment of soft tissue loss, especially in burns
and difficult wounds, e.g., pressure and vascular diabetic
ulcers, to become an essential resource.
Derivatives of hyaluronic acid (HA) are of particular
importance within the field of dermal replacement products
[2–7]. HA is the main degradation product in these sub-
stitutes and exerts many effects on wound healing,
including maintenance of the homeostasis [8], enhance-
ment of the angiogenesis [9] and organization of collagen
deposition [10]. HA benefits epithelial regeneration also,
and the HA macromolecule seems to have free-radical
scavenging properties. HA derivatives are available in
several esterified forms, one of which is HYAFF (benzyl
esters of hyaluronic acid), a biopolymer organized in a
three-dimensional scaffold that allows fibroblast coloniza-
tion producing an ordered reconstruction of dermal tissue
[11]. One of these recent HA derivatives is a dermal sub-
stitute composed by HYAFF, used in burn care practice as
biological regenerative matrix on both deep partial-thick-
ness and full-thickness burns and as temporary coverage of
the wounds [1, 12]. We have looked at the efficacy of this
substitute, originally developed for dermal regeneration in
different full-thickness wounds, for cases of limb trauma
with exposed bone or tendon which continue to be chal-
lenging problems for plastic surgeons. We have undertaken
this observational study to evaluate the clinical efficacy and
safety of the product on dermal regeneration in cases of
severe soft tissue loss.
Materials and methods
This prospective case series included 15 patients with full-
thickness wounds caused by trauma which were treated
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with the dermal substitute; the series was accrued from
June 2007 to May 2010. All patients were informed about
product use and consented to the study. There were 8 male
and 7 female patients with a mean age of 36.6 years. Eight
patients had trauma to the lower limbs and 7 were of the
upper limbs, with the average lesion size 104.4 cm2 (range
6–490 cm2), (Table 1). Twelve patients had exposed ten-
dons and two had exposed bone (no area of bone exposure
exceeded 2 cm2). The causes of trauma were, in ten cases
(66 %), accidents at work or home; in three cases (20 %),
burns and in two cases (13.3 %), surgical wounds. All
cases were treated urgently, and none of the patients was
affected by comorbidities. Evaluation of inflammatory
indexes (white cells, CRP and ESR) were carried out at 3,
6, 10 days and 4 weeks after the application of the product.
The assessment of clinical epithelialization and the aes-
thetic quality of the newly formed skin (skin texture, color
similarity and elasticity) were performed at least 6 weeks
after product application. In six patients (40 %), a second
application was necessary. The layer was left on the
wounds for a mean time of 15.9 days (range 14–21). Any
adverse events and complications were recorded.
Product application procedure
Hyalomatrix PA is designed as a sterile, bi-layered wound
dressing. It is a biodegradable, absorbent, non-woven pad
entirely composed of HYAFF which constitutes the
wound contact layer. The HYAFF layer is physically
coupled with a transparent and flexible film of a medical-
grade synthetic elastomer that acts as a semipermeable
barrier against external contaminants. As the product is
applied on the wound bed, the HYAFF wound contact
layer provides a three-dimensional scaffold that permits the
colonization of the product by fibroblasts and onto which
extracellular matrix components are laid down, resulting in
an almost ordered reconstruction of the dermal tissue. The
transparent elastomeric film, characterized by a vapor
transmission rate comparable to that of normal skin, pre-
vents excessive body fluid loss. The product conforms well
to wound edges and can be cut to suit the shape of the
lesion.
All wounds were subjected to a presurgical debridement
and assessment of the lesion. Hemostasis of the visible
bleeding points was carried out. Once a clean wound bed
was obtained, an adequate-sized pad was shaped to the
wound and applied with the HYAFF scaffold in direct
contact with the wound bed and contoured to the edges,
sutured with nylon sutures and dressed with sterile cotton
gauze. An elastic bandage was applied for a non-com-
pressing cover. After a period of not less than 15 days, a
complete inspection and assessment of the wound was
performed by removing the silicon film. Depending on the
achievement of the desired level of granulation tissue, it
was decided if a new application of the product was nec-
essary. If a wound bed with a good blood supply was
observed, repeated washing with saline was carried out and
dressing with paraffin gauze followed by cotton gauze and
a bandage applied. Patients returned for a change of
dressings weekly. Swabs were taken for bacteriologic
culture before application and thereafter at weekly intervals
during wound inspection. Antibiotic prophylaxis (Cefazo-
lin) was administered from the day of the product appli-
cation for 3 days until microbiological results were
Table 1 Demography and baseline characteristics
N Age
(years)
Sex Trauma
localization
Cause Lesion areaa
(cm2)
Bone
exposure
Tendon
lesion
Hyalomatrix
PA (n)
Hyalomatrix PA
residence time (days)
1 45 F Leg, third distal Accident 20 9 8 (160) ?(2 9 1 cm) ? 2 21 ? 21
2 33 M Hand Work accident 16 9 6 (96) – ? 1 14
3 17 M Hand Surgery 3 9 6 (18) – ? 1 14
4 19 M Forearm Work accident 4 9 8 (32) – ? 1 14
5 62 M Leg, third distal Accident 13 9 9 (117) – ? 2 21 ? 21
6 42 F Hand Home accident 6 9 4 (24) – ? 1 14
7 34 F Foot Accident 3 9 4 (12) – ? 1 14
8 29 F Foot Accident 6 9 7 (42) – ? 1 14
9 3 M Hand Burn 5 9 5 (25) – – 2 14 ? 14
10 48 M Foot Work accident 12 9 4 (48) – ? 2 14 ? 14
11 47 F Hand Burn 3 9 2 (6) – – 1 14
12 51 M Leg, third distal Surgery 35 9 14 (490) ?(2 9 1 cm) ? 2 21 ? 21
13 68 F Thigh Burn 20 9 16 (320) – – 2 14 ? 14
14 22 F Leg, third distal Accident 9 9 4 (36) – ? 1 14
15 30 M Forearm Work accident 20 9 7 (140) – ? 1 14
a Lesion area by maximum length and width
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available. Each patient with clinical evidence of infection
received appropriate antibiotic therapy (based on results of
cultures), and dressing changes were increased to twice per
week until the infection settled. Weekly dressing changes
continued until epithelial healing was complete. Regular
photographic documentation was taken before, during and
after treatment.
Results
All treated cases (n = 15) had satisfactory tissue repair
(Table 2). Out of 15 cases, 6 (40 %) needed a second
application of the product in order to obtain the desired
wound bed. Of the six, 3 had lesion sizes ranging from 117
to 390 cm2 needing autologous skin grafts to complete
wound cover. Ten lesions (67 %) closed spontaneously by
re-epithelialization (Fig. 1), but 5 cases (33 %) needed
autologous skin grafts to complete the epithelialization
process (Fig. 2). The time to complete healing had a mean
average time of 26.8 days (range 16–60 days). The
inflammatory indexes were normal in 13 cases (87 %)
while in two cases (13 %) were positive. The assessment of
the quality of the new skin was optimal for 5 cases
(33.3 %), good in 7 (46.6 %) and modest in 3 (20 %). In
one case (6.7 %), the onset of infection was observed, and
this event delayed the epithelialization process; in this case,
the second application of the product was postponed until a
decrease in the inflammatory markers. No other compli-
cations were noticed during the product application and
duration of the study.
Discussion
Limb injuries creating exposed bone or tendon continue to
be challenging problems for plastic surgeons. There is now
a better understanding of vascular anatomy of the lower leg
and better use of improved wound care technology which
has led to judicial use of flaps and delayed closures. Severe
limb trauma has significant socio-economic effects; there is
considerable expenditure in terms of direct costs (ortho-
pedic implants and devices, dressing materials, antibiotics)
and indirect costs (lost working days, family involvement,
transportation, etc.). For all these reasons, we have decided
to evaluate treatment of traumatic lesions of the limbs with
an advanced wound care dressing which proposes to pro-
mote and sustain effective coverage of bony and tendon
structures and, simultaneously, to accelerate the healing
process through an induction of the dermal component.
A previous clinical study with a product based on
Hyaluronic acid was carried out on deep partial and full-
thickness burns in young and adult patients [13]. In con-
trast, we have utilized this dermal substitute in severe
extremity injuries, although less life-threatening than burns
but still present as a difficult soft tissue problem for limb
salvage. These results suggest the product does induce the
production of new granulation tissue suitable for receiving
a new epithelial cover.
The effective protection provided by the layer of silicon
from infections was supported by the incidence of 1 case
with infection (6.7 %) in this series. The outer silicone
membrane barrier may limit colonization and therefore
protect the hyaluronan from protease digestion.
Table 2 Efficacy and safety
results
a Evaluation of inflammatory
indexes (white cells, C-RP and
ESR) were carried out at 3, 6,
10 days and 4 weeks after the
application of Hyalomatrix PA
b Evaluation at least 6 weeks
after Hyalomatrix PA
application (skin texture, skin
color similarity and elasticity)
N Inflammatory
indexesa
Skin
autograft
Time to
complete
healing
(days)
Quality
of the
skinb
Complications
1 Negative Yes 28 Moderate –
2 Positive No 30 Good –
3 Positive No 21 Optimal –
4 Positive Yes 21 Good –
5 Positive Yes 28 Optimal –
6 Positive No 23 Good –
7 Positive No 21 Optimal –
8 Positive No 16 Optimal –
9 Positive No 30 Normal –
10 Positive No 28 Good –
11 Positive No 16 Moderate –
12 Negative Yes 60 Moderate Infection
13 Positive Yes 28 Good –
14 Positive No 30 Good –
15 Positive No 23 Good –
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During this study, despite the transparent nature of the
external silicon layer, we were not able to verify specific
changes on the wound bed until removal of the product
around the fourteenth day of treatment. This observational
study has confirmed some remarkable induction capabili-
ties of this dermal substitute on producing granulation
tissue suitable for split skin grafts. Although pain relief was
demonstrated for the intra-articular introduction of
hyaluronic acid derivatives in the treatment of osteoar-
thritis [14, 15], we have not measured this clinical effect in
the patients in this study. Myers et al. [16–19] have pro-
posed a role of HA in the induction of angiogenesis in
granulation tissue. In a previous clinical study, Price et al.
[20, 21] have suggested that Hyalomatrix might function
as a dermal regenerative template because of its high level
of esterification in HYAFF, and this is supported by the
Fig. 1 Patient with traumatic
injury of the right hand.
a Lesion after surgical
debridement, b application of
Hyalomatrix PA, c lesion after
the Hyalomatrix removal,
d lesion completed healed
(after 30 days)
Fig. 2 Patient with a lower
limb traumatic lesion. a Lesion
after surgical debridement,
b application of Hyalomatrix
PA, c lesion after Hyalomatrix
PA removal: the newly formed
tissue is evident, d after one
month: [90 % taking of the
meshed-skin graft
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observation of early wound epithelialization. This study
has shown satisfactory results with this approach, but it
stressed the importance that close monitoring of wound
progress is made. For these reasons, we believe that a
hyaluronic acid-derived dermal substitute can be indicated
for non-invasive treatment of complicated traumatic
wounds where there is need for a dermal inductive effect to
cover important structures and a need of protection from
infections [13]. The quality of the neo-dermal tissue is
clinically better than dystrophic scar tissue that would be
obtained from healing by secondary intention, but it is not
yet comparable to that of the original healthy skin. On
certain locations such as hands, knees, elbows and ankles,
use of this substitute will need longer-term follow-up for
the possible onset of contractures which could affect
function. Finally, with this approach to wound cover, there
is need for high patient compliance and specific physio-
therapy aimed at functional recovery after the immobili-
zation of the treated area.
Conclusion
This study has evaluated the performance of a dermal
substitute for the cover of wounds to limbs after trauma.
Successful cover was achieved in all cases, with the need
of additional split thickness skin grafts in 33 % of patients.
Infection was encountered in one patient.
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